Article Information
History
- January 4, 2021.
Article Versions
- You are currently viewing Version 1 of this article (January 4, 2021 - 05:06).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Institute of Fundamental Technological Research, Polish Academy of Sciences, 02-106 Warsaw, Poland
- 2Inter-Faculty Individual Studies in Mathematics and Natural Sciences, The MISMaP College, University of Warsaw, 02-087 Warsaw, Poland
- ↵*Corresponding author’s e-mail: tlipnia{at}ippt.pan.pl
Posted January 04, 2021.
SARS-CoV-2 Variant Under Investigation 202012/01 has more than twofold replicative advantage
